Last $101.54 USD
Change Today -4.93 / -4.63%
Volume 666.6K
As of 8:10 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gary Patou M.D.

Chief Medical Officer, Pacira Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 5 different industries.

See Board Relationships
55$367,600
As of Fiscal Year 2013

Background*

Dr. Gary Patou, M.D. has been Senior Medical Advisor at Chiasma (Israel) ltd. since 2014. Dr. Patou serves as the Managing Director of MPM Capital. Dr. Patou joined MPM Capital in 2005. He has been the Chief Medical Officer Pacira Pharmaceuticals, Inc. since March 2009. He serves as Managing Director at MPM BioVentures IV, L.P. He served as Consultant at Peplin, Inc. since June 2008 until June 30, 2009. He served as Interim Chief Medical Officer of Peplin, Ltd. from ...

Read Full Background

Corporate Headquarters*

5 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-254-3560
Fax: --

Board Members Memberships*

2004-Present
Independent Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2005-2008
Former Director and Chairman of Compliance Committee

Education*

PhD
University College London
Bachelor's Degree
University College London
BS
University College London
MD
University College London

Other Affiliations*

Annual Compensation*

Salary$317,600
Bonus$50,000
Total Annual Compensation$367,600

Stock Options*

Exercised Options100,000
Exercised Options Value$3,139,341
Exercisable Options76,291
Exercisable Options Value$3,775,271
Unexercisable Options84,162
Unexercisable Options Value$4,054,251
Total Value of Options$10,968,862
Total Number of Options260,453

Total Compensation*

Total Annual Cash Compensation$367,600
Total Short Term Compensation$367,600
Total Calculated Compensation$367,600
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PCRX:US $101.54 USD -4.93

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Rajat Rai Chief Executive Officer
Akorn, Inc.
$250.0K
Benson F. Smith Chairman, Chief Executive Officer, President and Member of Non-Executive Equity Awards Committee
Teleflex Incorporated
$826.6K
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$620.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIRA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.